Singapore-based investment firm Temasek has invested $85 million in Goa-based Molbio Diagnostics. Motilal Oswal Alternates is Molbio's existing investor and Molbio will reportedly be valued at $1.6 billion after the funding round. Molbio Diagnostics, known for its Truenat technology, will be the 108th unicorn after Tata 1mg made it to the list earlier this month.